Skip Navigation

Cardiovascular Research 2000 48(1):44-58; doi:10.1016/S0008-6363(00)00155-3
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Walker, B. D
Right arrow Articles by Campbell, T. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, B. D
Right arrow Articles by Campbell, T. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel

Bruce D Walkera, Cameron B Singletona, Hui Tiea, Jane A Bursilla, Ken R Wysea, Stella M Valenzuelab, Samuel N Breitb and Terence J Campbella,*

aDepartment of Medicine, University of New South Wales and Victor Chang Cardiac Research Institute, St Vincent's Hospital, Sydney, Australia
bCentre for Immunology, St. Vincent's Hospital, Sydney, Australia

* Corresponding author. Tel.: +61-2-8382-2352; Fax: +61-2-8382-2794 t.campbell{at}unsw.edu.au

Objective: To evaluate the effects of azimilide and ambasilide on the biophysical properties of the human-ether-a-go-go-related (HERG) channel. Methods: HERG was stably transfected into Chinese hamster ovary (CHO-K1) cells and currents were measured using a whole cell, voltage-clamp technique. Results: Azimilide had a ‘dual effect’, inhibiting current at voltage steps above –40 mV and augmenting current at –40 and –50 mV. Tail current inhibition following a step to +30 mV did not vary with temperature (IC50 610 nM at 22°C and 560 nM at 37°C). The agonist effect at –50 mV was concentration-dependent and correlated with a hyperpolarizing shift in the V1/2 of activation (r = 0.98, P<0.05). Time constants of inactivation were faster and there was a –10 mV shift in the V1/2 of steady state inactivation suggestive of open and inactivated state binding. By comparison, ambasilide inhibited HERG channels with lower potency (IC50 3.6 µM), in a voltage- and time-dependent but frequency-independent manner (0.03–1 Hz). Ambasilide had no effect on activation or inactivation gating but prolonged both fast and slow components of deactivation consistent with unbinding from the open state. The net effect of both drugs was similar during a voltage ramp which simulated a cardiac action potential. Conclusions: Inhibition of HERG channels by azimilide and ambasilide exhibits a similar time and voltage-dependence. While both exhibit affinity for the open state, azimilide also binds to inactivated channels.

KEYWORDS Antiarrhythmic agents; Ion channels; K-channel; Long QT syndrome; Membrane currents; Repolarization


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
H. Sale, J. Wang, T. J. O'Hara, D. J. Tester, P. Phartiyal, J.-Q. He, Y. Rudy, M. J. Ackerman, and G. A. Robertson
Physiological Properties of hERG 1a/1b Heteromeric Currents and a hERG 1b-Specific Mutation Associated With Long-QT Syndrome
Circ. Res., September 26, 2008; 103(7): e81 - e95.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.